NCTM advises DOC Generici management on acquisition by Charterhouse Capital Partners
NCTM Studio Legale Associato has advised the management of pharmaceutical group DOC Generici — owned by Apotex, Chiesi Farmaceutici and Zambon — on the group’s buyout by private equity fund Charterhouse Capital Partners.
The NCTM team was led by Pietro Zanoni and made up of Francesca Bonino, Roberta Russo and Barbara Aloisi.
During the acquisition, Chiomenti Studio Legale assisted the buyer Charterhouse with Franco Agopyan (M&A), Luca Bonetti (finance), Paolo Giacometti (tax) and Stefania Bariatti (filing antitrust), while the vendors — Zambon, Chiesi Farmaceutici and Apotex — were assisted by Freshfields with Nicola Asti, Leonardo Graffi and Niccolò Gandini.
Rothschild acted as financial adviser to the vendors.
News from NCTM
Briefings from NCTM
One of the EPO Boards of Appeal has ruled on the highly debated issue of human stem cell patentability under the European Patent Convention.
On 7 February 2014, the European Court of Justice (Case 98-13) issued a ruling pertaining to the interpretation of Council Regulation (EC) no. 1383/2003.
Analysis from The Lawyer
Being sent to London on secondment is a prized opportunity for associates in European firms